Agilon Health (NYSE:AGL) and InnovAge (NASDAQ:INNV) Head-To-Head Analysis

InnovAge (NASDAQ:INNVGet Free Report) and Agilon Health (NYSE:AGLGet Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Volatility and Risk

InnovAge has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, Agilon Health has a beta of 0.06, meaning that its stock price is 94% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations and price targets for InnovAge and Agilon Health, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InnovAge 2 0 0 0 1.00
Agilon Health 2 12 4 0 2.11

InnovAge currently has a consensus price target of $5.00, indicating a potential downside of 4.94%. Agilon Health has a consensus price target of $2.71, indicating a potential upside of 278.79%. Given Agilon Health’s stronger consensus rating and higher probable upside, analysts plainly believe Agilon Health is more favorable than InnovAge.

Institutional & Insider Ownership

12.3% of InnovAge shares are held by institutional investors. 1.0% of InnovAge shares are held by company insiders. Comparatively, 3.6% of Agilon Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares InnovAge and Agilon Health”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
InnovAge $853.70 million 0.84 -$30.31 million ($0.13) -40.46
Agilon Health $6.06 billion 0.05 -$260.15 million ($0.75) -0.95

InnovAge has higher earnings, but lower revenue than Agilon Health. InnovAge is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares InnovAge and Agilon Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
InnovAge -1.96% -7.02% -3.31%
Agilon Health -5.24% -75.92% -18.35%

Summary

InnovAge beats Agilon Health on 8 of the 14 factors compared between the two stocks.

About InnovAge

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

About Agilon Health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.